Orthobiologics

Initial 12-month efficacy results from a Phase IIA trial demonstrate positive effects on pain and osteoporosis blood markers from a single...

FDA has accepted for filing Vericel’s BLA for MACI™, matrix-applied characterized autologous cultured chondrocytes intended to treat adult symptomatic knee cartilage...

At AAOS 2016, Bioventus is introducing the CellXtract™ novel cell and bone marrow extraction tool and SIGNAFUSE™, a bioactive bone graft putty. ...

AlloSource launched ProChondrix® Cartilage Restoration Matrix, a cellular 3D fresh allograft to support cartilage regeneration....

BONESUPPORT launched a 5mL version of CERAMENT™|G antibiotic-eluting bone substitute in the EU to support small joint and extremity indications....

Fidia will commence U.S. launch of Hymovis® 2-injection highly viscoelastic hyaluronan, indicated to treat knee OA pain....

Bone Therapeutics has treated 12 patients in the ALLOB® Phase IIA spinal fusion trial, and reports no safety concerns....

CollPlant announced positive final clinical trial results for Vergenix™STR, intended for the treatment of tendinopathy....

Histogenics has completed >50% of the required enrollment in its ongoing NeoCart® Phase III clinical trial in the treatment of knee cartilage defects....

Seikagaku and Kaken Pharmaceutical will discontinue development of SI-657, an additional indication of enthesopathy for the ARTZ injectable joint function-improving agent. ...